Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 19, 2023, titled "Sun Pharma Announces Health Canada Approval of PRWINLEVI�� (clascoterone cream 1%) for Topical Treatment of Acne".
Press Release Jun 19 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharma Announces China NMPA Approval for ILUMETRI for Treatment of Adults with Moderate-To-Severe Plaque Psoriasis
- Press Release May 30 2023
- Press Release May 26 2023
- Press Release Apr 25 2023
- Press Release Mar 22 2023
Later from Sun Pharmaceutical Industries
- Press Release Jun 24 2023
- Sun Pharma Announces Health Canada Approval of (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Nodular Acne
- Press Release Aug 03 2023
- Press Release Sep 14 2023
- Press Release Sep 27 2023
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries